FMO2 <sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma

Wenxin Xu, Jialei Weng, Yufei Zhao, Peiyi Xie, Minghao Xu, Shaoqing Liu, Qiang Yu, Mincheng Yu, Bugang Liang, Junbo Chen, Hui-Chuan Sun, Hui Li, Qinghai Ye, Yinghao Shen

Open source

DOI
10.1136/jitc-2025-011648
Published
2025-05
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-011648,
  title = {FMO2
                    <sup>+</sup>
                    cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma},
  author = {Wenxin Xu and Jialei Weng and Yufei Zhao and Peiyi Xie and Minghao Xu and Shaoqing Liu and Qiang Yu and Mincheng Yu and Bugang Liang and Junbo Chen and Hui-Chuan Sun and Hui Li and Qinghai Ye and Yinghao Shen},
  year = {2025},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2025-011648},
  url = {https://doi.org/10.1136/jitc-2025-011648}
}

RIS

TY  - JOUR
TI  - FMO2
                    <sup>+</sup>
                    cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma
AU  - Wenxin Xu
AU  - Jialei Weng
AU  - Yufei Zhao
AU  - Peiyi Xie
AU  - Minghao Xu
AU  - Shaoqing Liu
AU  - Qiang Yu
AU  - Mincheng Yu
AU  - Bugang Liang
AU  - Junbo Chen
AU  - Hui-Chuan Sun
AU  - Hui Li
AU  - Qinghai Ye
AU  - Yinghao Shen
PY  - 2025
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2025-011648
UR  - https://doi.org/10.1136/jitc-2025-011648
ER  - 

APA

Xu, W., Weng, J., Zhao, Y., Xie, P., Xu, M., Liu, S., Yu, Q., Yu, M., Liang, B., Chen, J., Sun, H., Li, H., Ye, Q., & Shen, Y. (2025). FMO2 <sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-011648

Source records